These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 37511838)

  • 1. Phosphorylation Mimetic of Myosin Regulatory Light Chain Mitigates Cardiomyopathy-Induced Myofilament Impairment in Mouse Models of RCM and DCM.
    Kazmierczak K; Liang J; Maura LG; Scott NK; Szczesna-Cordary D
    Life (Basel); 2023 Jun; 13(7):. PubMed ID: 37511838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional comparison of phosphomimetic S15D and T160D mutants of myosin regulatory light chain exchanged in cardiac muscle preparations of HCM and WT mice.
    Kazmierczak K; Liang J; Gomez-Guevara M; Szczesna-Cordary D
    Front Cardiovasc Med; 2022; 9():988066. PubMed ID: 36204565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphomimetic-mediated in vitro rescue of hypertrophic cardiomyopathy linked to R58Q mutation in myosin regulatory light chain.
    Yadav S; Kazmierczak K; Liang J; Sitbon YH; Szczesna-Cordary D
    FEBS J; 2019 Jan; 286(1):151-168. PubMed ID: 30430732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanistic basis for rescuing hypertrophic cardiomyopathy with myosin regulatory light chain phosphorylation.
    Liang J; Kazmierczak K; Veerasammy M; Yadav S; Takeuchi L; Kanashiro-Takeuchi R; Szczesna-Cordary D
    Cytoskeleton (Hoboken); 2024 Dec; 81(12):806-814. PubMed ID: 38494592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiomyopathic mutations in essential light chain reveal mechanisms regulating the super relaxed state of myosin.
    Sitbon YH; Diaz F; Kazmierczak K; Liang J; Wangpaichitr M; Szczesna-Cordary D
    J Gen Physiol; 2021 Jul; 153(7):. PubMed ID: 34014247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular basis of force-pCa relation in
    Yuan CC; Kazmierczak K; Liang J; Ma W; Irving TC; Szczesna-Cordary D
    Proc Natl Acad Sci U S A; 2022 Feb; 119(8):. PubMed ID: 35177471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic potential of AAV9-S15D-RLC gene delivery in humanized MYL2 mouse model of HCM.
    Yadav S; Yuan CC; Kazmierczak K; Liang J; Huang W; Takeuchi LM; Kanashiro-Takeuchi RM; Szczesna-Cordary D
    J Mol Med (Berl); 2019 Jul; 97(7):1033-1047. PubMed ID: 31101927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Constitutive phosphorylation of cardiac myosin regulatory light chain prevents development of hypertrophic cardiomyopathy in mice.
    Yuan CC; Muthu P; Kazmierczak K; Liang J; Huang W; Irving TC; Kanashiro-Takeuchi RM; Hare JM; Szczesna-Cordary D
    Proc Natl Acad Sci U S A; 2015 Jul; 112(30):E4138-46. PubMed ID: 26124132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel familial dilated cardiomyopathy mutation in MYL2 affects the structure and function of myosin regulatory light chain.
    Huang W; Liang J; Yuan CC; Kazmierczak K; Zhou Z; Morales A; McBride KL; Fitzgerald-Butt SM; Hershberger RE; Szczesna-Cordary D
    FEBS J; 2015 Jun; 282(12):2379-93. PubMed ID: 25825243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro rescue study of a malignant familial hypertrophic cardiomyopathy phenotype by pseudo-phosphorylation of myosin regulatory light chain.
    Muthu P; Liang J; Schmidt W; Moore JR; Szczesna-Cordary D
    Arch Biochem Biophys; 2014 Jun; 552-553():29-39. PubMed ID: 24374283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydroxychloroquine Mitigates Dilated Cardiomyopathy Phenotype in Transgenic D94A Mice.
    Kanashiro-Takeuchi RM; Kazmierczak K; Liang J; Takeuchi LM; Sitbon YH; Szczesna-Cordary D
    Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ablation of the N terminus of cardiac essential light chain promotes the super-relaxed state of myosin and counteracts hypercontractility in hypertrophic cardiomyopathy mutant mice.
    Sitbon YH; Kazmierczak K; Liang J; Yadav S; Veerasammy M; Kanashiro-Takeuchi RM; Szczesna-Cordary D
    FEBS J; 2020 Sep; 287(18):3989-4004. PubMed ID: 32034976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular mechanisms of cardiomyopathy phenotypes associated with myosin light chain mutations.
    Huang W; Szczesna-Cordary D
    J Muscle Res Cell Motil; 2015 Dec; 36(6):433-45. PubMed ID: 26385864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sarcomeric perturbations of myosin motors lead to dilated cardiomyopathy in genetically modified
    Yuan CC; Kazmierczak K; Liang J; Zhou Z; Yadav S; Gomes AV; Irving TC; Szczesna-Cordary D
    Proc Natl Acad Sci U S A; 2018 Mar; 115(10):E2338-E2347. PubMed ID: 29463717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hereditary heart disease: pathophysiology, clinical presentation, and animal models of HCM, RCM, and DCM associated with mutations in cardiac myosin light chains.
    Yadav S; Sitbon YH; Kazmierczak K; Szczesna-Cordary D
    Pflugers Arch; 2019 May; 471(5):683-699. PubMed ID: 30706179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular and Functional Effects of a Splice Site Mutation in the MYL2 Gene Associated with Cardioskeletal Myopathy and Early Cardiac Death in Infants.
    Zhou Z; Huang W; Liang J; Szczesna-Cordary D
    Front Physiol; 2016; 7():240. PubMed ID: 27378946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypercontractile mutant of ventricular myosin essential light chain leads to disruption of sarcomeric structure and function and results in restrictive cardiomyopathy in mice.
    Yuan CC; Kazmierczak K; Liang J; Kanashiro-Takeuchi R; Irving TC; Gomes AV; Wang Y; Burghardt TP; Szczesna-Cordary D
    Cardiovasc Res; 2017 Aug; 113(10):1124-1136. PubMed ID: 28371863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypertrophic cardiomyopathy associated E22K mutation in myosin regulatory light chain decreases calcium-activated tension and stiffness and reduces myofilament Ca
    Zhang J; Wang L; Kazmierczak K; Yun H; Szczesna-Cordary D; Kawai M
    FEBS J; 2021 Aug; 288(15):4596-4613. PubMed ID: 33548158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of myosin RLC phosphorylation in normal and cardiomyopathic mouse hearts.
    Muthu P; Kazmierczak K; Jones M; Szczesna-Cordary D
    J Cell Mol Med; 2012 Apr; 16(4):911-9. PubMed ID: 21696541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual effect of N-terminal deletion of cardiac myosin essential light chain in mitigating cardiomyopathy.
    Sitbon YH; Kazmierczak K; Liang J; Kloehn AJ; Vinod J; Kanashiro-Takeuchi R; Szczesna-Cordary D
    iScience; 2024 Aug; 27(8):110591. PubMed ID: 39211545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.